Home » Topics » Regulatory

Regulatory
RSS

FDA approves Pfizer's bosutinib for CML

Sep. 5, 2012

Teduglutide receives European marketing authorization for short bowel syndrome

Sep. 5, 2012

FDA approves Xtandi for metastatic castration-resistant prostate cancer

Sep. 3, 2012

New drug approved for IBS-C and CIC

Aug. 31, 2012

Nucynta ER approved for new indication in U.S.

Aug. 30, 2012

European Commission approves Zinforo

Aug. 29, 2012

NeutroPhase cleared for use in new indications

Aug. 28, 2012

FDA approves new combination pill for HIV

Aug. 28, 2012

Growject approved for fourth indication in Japan

Aug. 24, 2012

FDA approves sNDA for Tradjenta

Aug. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ASH 2025: New blood cancer therapies trump chemo, older drugs
BioWorld
Targeted therapies and immunotherapies continue to show better results than chemotherapy in investigator-initiated and company-sponsored cancer trials, and newer...